Penella J Woll Selected Research

Doxorubicin (Adriamycin)

1/2019	The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
10/2017	Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
10/2012	Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Penella J Woll Research Topics

Disease

15	Neoplasms (Cancer) 12/2020 - 07/2004
12	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2003
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 07/2008
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 01/2003
6	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 01/2006
6	Neoplasm Metastasis (Metastasis) 02/2016 - 07/2008
4	Neutropenia 10/2017 - 02/2013
4	Exanthema (Rash) 11/2012 - 03/2009
3	Pain (Aches) 10/2017 - 03/2014
3	Multiple Myeloma 03/2014 - 03/2011
3	Hypocalcemia 03/2014 - 03/2011
2	Mesothelioma 12/2020 - 01/2020
2	Disease Progression 10/2017 - 11/2012
2	Hemangiosarcoma (Angiosarcoma) 01/2017 - 08/2014
2	Prostatic Neoplasms (Prostate Cancer) 07/2015 - 03/2011
2	Osteonecrosis (Kienbock's Disease) 03/2014 - 12/2012
2	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2009 - 08/2009
2	Constipation 11/2009 - 08/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2009 - 08/2009
2	Diarrhea 08/2009 - 03/2009
1	Carcinogenesis 01/2022
1	Adenocarcinoma of Lung 01/2020
1	Malignant Mesothelioma 01/2020
1	Nausea 01/2020
1	Inflammation (Inflammations) 01/2019
1	Febrile Neutropenia 10/2017
1	Fatigue 10/2017
1	Fever (Fevers) 10/2017
1	Stomatitis 10/2017
1	Radiation Pneumonitis 01/2017
1	Hemorrhage 02/2016
1	Hypertension (High Blood Pressure) 08/2015
1	Spinal Cord Compression 07/2015
1	Adenocarcinoma 02/2015
1	Leukopenia 02/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2012
1	Brain Neoplasms (Brain Tumor) 11/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2009
1	Embolism (Embolus) 08/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2008
1	Muscle Cramp (Cramp) 01/2006

Drug/Important Bio-Agent (IBA)

4	Cell-Free Nucleic AcidsIBA 01/2016 - 09/2006
4	Zoledronic Acid (Zometa)FDA Link 07/2015 - 03/2011
4	Denosumab FDA Link 07/2015 - 03/2011
3	PlatinumIBA 01/2020 - 01/2017
3	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 11/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 10/2012
3	Gemcitabine FDA Link 10/2017 - 11/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 07/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014 - 06/2005
3	NeuropeptidesIBA 06/2005 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2017
2	Ifosfamide FDA LinkGeneric 01/2019 - 10/2012
2	Docetaxel (Taxotere)FDA Link 10/2017 - 02/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2012 - 03/2009
2	Thalidomide (Thalomid)FDA Link 11/2009 - 08/2009
2	Interleukin-8 (Interleukin 8)IBA 07/2008 - 10/2005
2	Imatinib Mesylate (Gleevec)FDA Link 02/2008 - 01/2006
2	Neuropeptide Receptors (Neuropeptide Receptor)IBA 01/2003 - 01/2003
2	RE1-silencing transcription factorIBA 01/2003 - 01/2003
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	CytokinesIBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Folic Acid AntagonistsIBA 01/2020
1	STA 9090IBA 01/2020
1	HLA-A Antigens (HLA-A)IBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	Biological ProductsIBA 01/2020
1	ElementsIBA 01/2019
1	eribulin FDA Link 04/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2016
1	lorvotuzumab mertansineIBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Maytansine (Maitansine)IBA 01/2016
1	pazopanib FDA Link 08/2015
1	Alanine Transaminase (SGPT)IBA 08/2015
1	cabozantinibIBA 07/2015
1	Radium-223IBA 07/2015
1	ORALIT (ORS)IBA 02/2015
1	IntegrinsIBA 02/2013
1	CilengitideIBA 02/2013
1	Monoclonal AntibodiesIBA 12/2012
1	LenograstimIBA 10/2012
1	RANK LigandIBA 03/2011
1	Angiogenesis InhibitorsIBA 11/2009
1	SmokeIBA 03/2009
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2008
1	CalciumIBA 01/2006
1	Quinine (Quinson)FDA Link 01/2006
1	ElectrolytesIBA 01/2006
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2006

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2020 - 05/2005
4	Therapeutics 12/2020 - 08/2009
3	Adjuvant Chemotherapy 01/2019 - 10/2012
2	Radiotherapy 01/2017 - 07/2015
1	Chemoradiotherapy 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017